Delivery Order SPE2DB20D2104-SPE2DB26FMAHG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, which serves as the company's corporate...
- AmerisourceBergen Drug Corp was awarded a $2,425.00 delivery order by the Defense Logistics Agency (DLA) on October 17, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price contract with an ultimate completion date of October 20, 2025, and represents a child contract under a larger indefinite delivery vehicle. The award was made through competitive procurement with no set-aside designation. Performance will be executed from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 50 mg tablets (90-count units) at a ceiling value of $2,182.92. This competitively awarded, firm fixed-price delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and is set...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Januvia 25 mg tablets (90-count) under a firm fixed-price contract valued at $2,977.41. This delivery order represents a child contract action issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,365.84 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) on September 29, 2025, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical delivery under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Januvia 100 mg tablets (90-count) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by September 16, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAHGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $2,219.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract specifies an ultimate completion date of October 20, 2025, and identifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. This delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA. This award is part of AmerisourceBergen's significant engagement with the Defense Logistics Agency's Medical Supply Chain, where the company serves as a major pharmaceutical distributor for federal military and veteran healthcare systems. The company holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 through December 2026, which provides the overarching vehicle for fulfilling diverse pharmaceutical and medical supply requirements across multiple therapeutic domains. As a critical vendor for federal medical procurement, AmerisourceBergen regularly delivers brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/17/25 |